AppLovin: Shedding Latency And Entering The High Throughput Phase #AppLovin #Shedding #Latency #Entering #High #Throughput #Phase
Tag: Phase
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies#Press #Release…
Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in…
Intellia reports progress in Phase 3 clinical trials
Intellia reports progress in Phase 3 clinical trials#Intellia #reports #progress #Phase #clinical #trials
Prothena: Despite Phase 3 Trial Failure, Other Neurodegenerative Programs In Place
Prothena: Despite Phase 3 Trial Failure, Other Neurodegenerative Programs In Place #Prothena #Phase #Trial #Failure #Neurodegenerative…
Savara Presented New Data From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at American Thoracic
Savara Presented New Data From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in…
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial…
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with…
First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson's disease
First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson's disease#patients…
CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript)
CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript) #CytomX #Therapeutics #CTMX #CX2051…
Port of Cromarty Firth awards Phase 5 pre-construction contract to RJ McLeod
Port of Cromarty Firth has awarded a £1.5 million contract to RJ McLeod to carry out…
IBIT: Bitcoin Might Be Entering The Parabolic Phase
IBIT: Bitcoin Might Be Entering The Parabolic Phase #IBIT #Bitcoin #Entering #Parabolic #Phase
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster…
American Tower's Quiet Phase May Be Ending – Why It Still Has Legs To Run
American Tower's Quiet Phase May Be Ending – Why It Still Has Legs To Run #American…
Oracle NetSuite’s Goldberg: autonomous AI next applications phase
Evan Goldberg, executive vice-president of Oracle NetSuite, has a computer science student hinterland in artificial…
Factbox-EU's plan to phase out Russian gas by end-2027
Factbox-EU's plan to phase out Russian gas by end-2027#FactboxEU039s #plan #phase #Russian #gas #end2027
Redx Pharma's RXC008 shows promise in Phase 1 trial for Crohn's disease
Redx Pharma's RXC008 shows promise in Phase 1 trial for Crohn's disease#Redx #Pharma039s #RXC008 #shows #promise…
Netanyahu to convene ministers on new phase of Gaza war and aid
Netanyahu to convene ministers on new phase of Gaza war and aid#Netanyahu #convene #ministers #phase #Gaza…
Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden
Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden#Preliminary #Phase…
UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Inva
UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial…
Repsol starts producing electricity at Antofagasta Phase 1
Repsol has started producing electricity at Antofagasta Phase 1, its largest wind farm to date and…
VSB Group enters final phase of one of Europe’s largest repowering projects
The repowering of the Elster wind farm, developed by the VSB Group, is entering its final…